Table: Stella Pharma -2024/25 parent results

Stella Pharma

09/05/2025 06:01

May 9 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2025    Mar 31, 2024    Mar 31, 2026      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          961 mln         269 mln          1.01                   
              (+256.6 pct)     (+17.6 pct)     (+4.8 pct)                
  Operating    loss 90 mln    loss 760 mln    loss 348 mln               
  Recurring   loss 137 mln    loss 760 mln    loss 345 mln               
  Net         loss 140 mln    loss 763 mln    loss 348 mln               
  EPS         loss 4.22 yen  loss 24.66 yen  loss 10.23 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T